[1] Pitout JDD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8: 159–66. https://doi.org/10.1016/S1473-3099(08)70041-0.
[2] van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence 2017;8:460–9. https://doi.org/10.1080/ 21505594.2016.1222343.
[3] Rodríguez-Ban˜o J, Guti´errez-Guti´errez B, Machuca I, Pascual A. Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC—, and carbapenemase-producing Enterobacteriaceae. Clin Microbiol Rev 2018;31. https:// doi.org/10.1128/CMR.00079-17. e00079-17.
[4] Giske CG, Monnet DL, Cars O, Carmeli Y. ReAct-Action on antibiotic resistance. Clinical and economic impact of common multidrug-resistant Gram-negative bacilli. Antimicrob Agents Chemother 2008;52:813–21. https://doi.org/10.1128/ AAC.01169-07.
[5] Tumbarello M, Spanu T, Di Bidino R, Marchetti M, Ruggeri M, Trecarichi EM, et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-β-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother 2010;54:4085–91. https://doi.org/ 10.1128/AAC.00143-10.
[6] Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase- producing Enterobacteriaceae. Antimicrob Agents Chemother 2006;50:1257–62. https://doi.org/10.1128/AAC.50.4.1257-1262.2006.
[7] Bartsch SM, McKinnell JA, Mueller LE, Miller LG, Gohil SK, Huang SS, et al. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect 2017;23:48. https://doi.org/10.1016/j. cmi.2016.09.003. e9–48.e16.
[8] Kohler PP, Volling C, Green K, Uleryk EM, Shah PS, McGeer A. Carbapenem resistance, initial antibiotic therapy, and mortality in Klebsiella pneumoniae bacteremia: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2017;38:1319–28. https://doi.org/10.1017/ice.2017.197.
[9] Rohde AM, Zweigner J, Wiese-Posselt M, Schwab F, Behnke M, Kola A, et al. Prevalence of third-generation cephalosporin-resistant Enterobacterales colonization on hospital admission and ESBL genotype-specific risk factors: a cross- sectional study in six German university hospitals. J Antimicrob Chemother 2020; 75:1631–8. https://doi.org/10.1093/jac/dkaa052.
[10] Flokas ME, Alevizakos M, Shehadeh F, Andreatos N, Mylonakis E. Extended- spectrum β-lactamase-producing Enterobacteriaceae colonisation in long-term care facilities: a systematic review and meta-analysis. Int J Antimicrob Agents 2017;50: 649–56. https://doi.org/10.1016/j.ijantimicag.2017.08.003.
[11] Bar-Yoseph H, Hussein K, Braun E, Paul M. Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis. J Antimicrob Chemother 2016;71:2729–39. https://doi. org/10.1093/jac/dkw221.
[12] Kato D, Morioka H, Tomita Y, Iguchi M, Hirabayashi A, Tetsuka N, et al. Active surveillance in response to the identification of a single carbapenemase-producing Escherichia coli at a Japanese university hospital. J Infect Chemother 2018;24: 1013–5. https://doi.org/10.1016/j.jiac.2018.05.013.
[13] Friedman ND, Carmeli Y, Walton AL, Schwaber MJ. Carbapenem-resistant Enterobacteriaceae: a strategic roadmap for infection control. Infect Control Hosp Epidemiol 2017;38:580–94. https://doi.org/10.1017/ice.2017.42.
[14] Luvsansharav UO, Hirai I, Niki M, Nakata A, Yoshinaga A, Yamamoto A, et al. Fecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan. Infect Drug Resist 2013;6:67–70. https://doi.org/ 10.2147/IDR.S43868.
[15] Yokoyama K, Uehara Y, Sasaki T, Hiramatsu K. Risk factors of fecal colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae in special nursing homes in Japan. J Gen Fam Med 2018;19:90–6. https://doi.org/10.1002/ jgf2.161.
[16] Nakamura A, Komatsu M, Noguchi N, Ohno Y, Hashimoto E, Matsutani H, et al. Analysis of molecular epidemiologic characteristics of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli colonizing feces in hospital patients and community dwellers in a Japanese city. J Infect Chemother 2016;22:102–7. https://doi.org/10.1016/j.jiac.2015.11.001.
[17] Hagiya H, Yamamoto N, Kawahara R, Akeda Y, Shanmugakani RK, Ueda A, et al. Risk factors for fecal carriage of IMP-6-producing Enterobacteriaceae at a long-term care hospital in Japan: a follow-up report from the northern Osaka multicentre study group. J Infect Chemother 2018;24:769–72. https://doi.org/10.1016/j. jiac.2018.03.009.
[18] Asai N, Sakanashi D, Suematsu H, Kato H, Hagihara M, Nishiyama N, et al. The epidemiology and risk factor of carbapenem-resistant Enterobacteriaceae colonization and infections: case control study in a single institute in Japan. J Infect Chemother 2018;24:505–9. https://doi.org/10.1016/j.jiac.2018.02.005.
[19] Clinical and Laboratory Standards Institute. Performance Standards for antimicrobial susceptibility testing. Twenty-third informational supplement M100- S23. Wayne, Pennsylvania USA: CLSI; 2013.
[20] Arakawa Y, Shibata N, Shibayama K, Kurokawa H, Yagi T, Hujiwara H, et al. Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thiol compounds. J Clin Microbiol 2000;38(1):40–3. https://doi. org/10.1128/JCM.38.1.40-43.2000.
[21] Yagi T, Wachino J, Kurokawa H, Suzuki S, Yamane K, Doi Y, et al. Practical methods using boronic acid compounds for identification of class C β-lactamase- producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 2005;43(6): 2551–8. https://doi.org/10.1128/JCM.43.6.2551–2558.2005.
[22] Doi Y, Potoski BA, Adams-Haduch JM, Sidjabat HE, Pasculle AW, Paterson DL. Simple disk-based method for detection of Klebsiella pneumoniae carbapenemase- type β-lactamase by use of a boronic acid compound. J Clin Microbiol 2008;46(12): 4083–6. https://doi.org/10.1128/JCM.01408-08.
[23] Dallenne C, Da Costa A, Decr´e D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010;65:490–5. https://doi.org/ 10.1093/jac/dkp498.
[24] P´erez-P´erez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002;40: 2153–62. https://doi.org/10.1128/JCM.40.6.2153-2162.2002.
[25] Senda K, Arakawa Y, Ichiyama S, Nakashima K, Ito H, Ohsuka S, et al. PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams. J Clin Microbiol 1996;34:2909–13. https://doi. org/10.1128/jcm.34.12.2909-2913.1996.
[26] L´evesque C, Piche´ L, Larose C, Roy PH. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995;39: 185–91. https://doi.org/10.1128/AAC.39.1.185.
[27] Infectious Agents Surveillance Report. http://www.nih.go.jp/niid/ja/isar.html; 2014. 35, 12, 285-286.
[28] Kojima A, Ishii Y, Ishihara K, Esaki H, Asai T, Oda C, et al. Extended-spectrum-beta- lactamase-producing Escherichia coli strains isolated from farm animals from 1999 to 2002: report from the Japanese veterinary antimicrobial resistance monitoring program. Antimicrob Agents Chemother 2005;49:3533–7. https://doi.org/ 10.1128/aac.49.8.3533-3537.2005.
[29] Rooney PJ, O’Leary MC, Loughrey AC, McCalmont M, Smyth B, Donaghy P, et al. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)- producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother 2009; 64:635–41. https://doi.org/10.1093/jac/dkp220.
[30] Marchaim D, Chopra T, Bogan C, Bheemreddy S, Sengstock D, Jagarlamudi R, et al. The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities. Am J Infect Control 2012;40: 760–5. https://doi.org/10.1016/j.ajic.2011.09.011.
[31] Willemsen I, Nelson J, Hendriks Y, Mulders A, Verhoeff S, Mulder P, et al. Extensive dissemination of extended spectrum β-lactamase–producing Enterobacteriaceae in a Dutch nursing home. Infect Control Hosp Epidemiol 2015; 36:394–400. https://doi.org/10.1017/ice.2014.76.
[32] Ben-David D, Masarwa S, Adler A, Mishali H, Carmeli Y, Schwaber MJ. A national intervention to prevent the spread of carbapenem-resistant Enterobacteriaceae in Israeli post-acute care hospitals. Infect Control Hosp Epidemiol 2014;35:802–9. https://doi.org/10.1086/676876.
[33] Toth DJA, Khader K, Slayton RB, Kallen AJ, Gundlapalli AV, O’Hagan JJ, et al. The potential for interventions in a long-term acute care hospital to reduce transmission of carbapenem-resistant Enterobacteriaceae in affiliated healthcare facilities. Clin Infect Dis 2017;65:581–7. https://doi.org/10.1093/cid/cix370.
[34] Matsumura Y, Johnson JR, Yamamoto M, Nagao M, Tanaka M, Takakura S, et al. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic. J Antimicrob Chemother 2015;70:1639–49. https://doi.org/10.1093/jac/dkv017.
[35] Kawamura K, Hayashi K, Matsuo N, Kitaoka K, Kimura K, Wachino JI, et al. Prevalence of CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli B2-O25-ST131 H30R among residents in nonacute care facilities in Japan. Microb Drug Resist 2018;24:1513–20. https://doi.org/10.1089/mdr.2018.0068.
[36] Cochard H, Aubier B, Quentin R, van der Mee-Marquet N, R´eseau des Hygi´enistes du Centre. Extended-spectrum β-lactamase-producing Enterobacteriaceae in French nursing homes: an association between high carriage rate among residents, environmental contamination, poor conformity with good hygiene practice, and putative resident-to-resident transmission. Infect Control Hosp Epidemiol 2014;35: 384–9. https://doi.org/10.1086/675599.
[37] Tacconelli E, Mazzaferri F, de Smet AM, Bragantini D, Eggimann P, Huttner BD, et al. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers. Clin Microbiol Infect 2019;25:807–17. https:// doi.org/10.1016/j.cmi.2019.01.005.
[38] Ben-David D, Masarwa S, Fallach N, Temkin E, Solter E, Carmeli Y, et al. Success of a national intervention in controlling carbapenem-resistant Enterobacteriaceae in Israel’s long-term care facilities. Clin Infect Dis 2019;68:964–71. https://doi.org/ 10.1093/cid/ciy572.
[39] Cassir N, Delarozi`ere JC, Dubourg G, Delord M, Lagier JC, Brouqui P, et al. A regional outbreak of Clostridium difficile PCR-ribotype 027 infections in southeastern France from a single long-term care facility. Infect Control Hosp Epidemiol 2016;37:1337–41. https://doi.org/10.1017/ice.2016.164.